Curis, Inc. to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference at 8:00 a.m. PDT on March 17, 2010, in Dana Point, California.

Back to news